Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Onur Yazdan, Balcik"'
Autor:
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We aimed to compare FOLFIRI and bevacizumab with FOLFIRI and aflibercept in terms of overall survival (OS), progression-free survival (PFS) and safety in patients with RAS-mutant metastatic colon cancer who progressed after first-line FOLFOX
Externí odkaz:
https://doaj.org/article/b37a215f01c6451b946652f120eabbc8
Autor:
Omer Acar, Onur Yazdan Balcik, Muslih Urun, Tugay Avci, Mustafa Sahbazlar, Atike Pinar Erdogan
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e38809- (2024)
Objective: The pivotal prognostic determinant for recurrence and survival in surgically treated gastric cancer (GC) patients remains the lymph node status. Despite the adoption of D2 lymph node dissection as the standard approach in recent years, its
Externí odkaz:
https://doaj.org/article/0f816d9d63764c1d8fd593d36e758fad
Autor:
Yusuf ILHAN, Onur Yazdan BALCIK
Publikováno v:
Medicine Science, Vol 12, Iss 2, Pp 527-31 (2023)
Cancer screening programs are carried out worldwide and in our country to diagnose breast cancer in its early stage, before the disease shows any symptoms. In this study, we aimed to evaluate the knowledge, attitudes, and behaviors of non-physician h
Externí odkaz:
https://doaj.org/article/b4adc3ca8a4348fa87cecc4d24e7cdf5
Autor:
Ferhat, Ekinci, Onur Yazdan, Balcik, Bilgin, Demir, Pinar, Gursoy, Ahmet, Ozveren, Atike Pinar, Erdogan
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 32:996-1003
To evaluate the prognostic significance of the new index designed by formulating neutrophil, lymphocyte, and platelet counts in patients with metastatic disease receiving immune checkpoint inhibitors (ICI) and its effect on the immune-related adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1897fc0de1f043b7cea58cfb456204e4
https://doi.org/10.29271/jcpsp.2022.08.996
https://doi.org/10.29271/jcpsp.2022.08.996
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 32(3)
To evaluate prognostic significance of the new index, designed by formulating hemoglobin, albumin, lymphocyte, and platelet (HALP) counts in patients with metastatic renal cell carcinoma (RCC).Descriptive study.Department of Medical Oncology, Celal B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bbed11f7d029c6a7e9783413fd6c135
https://pubmed.ncbi.nlm.nih.gov/35148582
https://pubmed.ncbi.nlm.nih.gov/35148582